MORGAN TURNER: Open Payments
NPI 1609295906 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,124 in 99 payments from 17 companies in 2025. Trend: 2023 $92 · 2024 $1,419 · 2025 $2,124
Food & beverage: $2,124
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 18 | $532 |
| Alkermes, Inc. | 11 | $263 |
| ABBVIE INC. | 13 | $220 |
| Vanda Pharmaceuticals Inc. | 7 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $147 |
| Otsuka America Pharmaceutical, Inc. | 13 | $140 |
| Lundbeck LLC | 5 | $129 |
| Corium, LLC | 5 | $107 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Almatica Pharma LLC | 4 | $67 |
Products named: INGREZZA, REXULTI, VRAYLAR, LYBALVI, FANAPT, CAPLYTA, Azstarys, Auvelity.
Industry payments across TN — which companies pay providers there.
